Literature DB >> 17447068

[Transitional cell carcinoma of the ovary. Morphological and clinical features].

F Kommoss1, S Kommoss, J Eichhorn, D Schmidt.   

Abstract

Transitional cell carcinoma of the ovary (TCC-O) is a less common type of malignant surface epithelial-stromal tumor of the ovary, still with uncertain incidence. Histologically, TCC-O resembles urothelial carcinoma of the urinary system, and by definition does not contain a Brenner tumor component. TCC-O may not be a bona fide urothelial neoplasm, however, but rather a lesion of the Müllerian type derived from the ovarian surface epithelium. This notion is supported by the existence of mixed tumors consisting of TCC-O and other histological types of ovarian carcinoma, as well as the observation that TCC-O has a Müllerian type but not a urothelial-like immunohistochemical profile. Besides metastatic urothelial carcinoma of the urinary tract, the other types of ovarian carcinoma, as well as sex cord-stromal tumors such as adult granulosa cell tumors, have to be considered in the differential diagnosis of TCC-O. A recent analysis of a large series of advanced ovarian carcinomas treated by radical surgery and postoperative chemotherapy confirms studies that had suggested that TCC-O has a better prognosis (with current treatment) than that of the other histological types of ovarian carcinoma. Further studies applying standardized histopathological criteria are needed to clarify the true incidence and behavior of TCC-O. In addition, it is important to study the biological and molecular background of this apparently less aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447068     DOI: 10.1007/s00292-007-0912-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4).

Authors:  M J Costa; C Hansen; A Dickerman; S A Scudder
Journal:  Am J Clin Pathol       Date:  1998-02       Impact factor: 2.493

2.  Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel.

Authors:  Friedrich Kommoss; Stefan Kommoss; Dietmar Schmidt; Marcus J Trunk; Jacobus Pfisterer; Andreas du Bois
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

3.  Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy.

Authors:  D M Gershenson; E G Silva; M F Mitchell; E N Atkinson; J T Wharton
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

4.  Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.

Authors:  I Riedel; B Czernobilsky; B Lifschitz-Mercer; L M Roth; X R Wu; T T Sun; R Moll
Journal:  Virchows Arch       Date:  2001-02       Impact factor: 4.064

5.  Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.

Authors:  N G Ordóñez
Journal:  Histopathology       Date:  2000-05       Impact factor: 5.087

6.  Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.

Authors:  R A Soslow; R V Rouse; M R Hendrickson; E G Silva; T A Longacre
Journal:  Int J Gynecol Pathol       Date:  1996-07       Impact factor: 2.762

7.  Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.

Authors:  F Kommoss; E Oliva; A K Bhan; R H Young; R E Scully
Journal:  Mod Pathol       Date:  1998-07       Impact factor: 7.842

8.  Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.

Authors:  Sanjay Logani; Esther Oliva; Mahul B Amin; Andrew L Folpe; Cynthia Cohen; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

9.  Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy.

Authors:  S S Robey; E G Silva; D M Gershenson; D McLemore; A el-Naggar; N G Ordonez
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

10.  Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.

Authors:  R M Austin; H J Norris
Journal:  Int J Gynecol Pathol       Date:  1987       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.